Latasa, M. U., Gil-Puig, C., Fernández-Barrena, M. G., Rodríguez-Ortigosa, C. M., Banales, J. M., Urtasun, R., . . . Avila, M. A. (2010). Oral methylthioadenosine administration attenuates fibrosis and chronic liver disease progression in Mdr2-/- mice. Public Library of Science (PLoS).
Cita Chicago Style (17a ed.)Latasa, M Ujue, et al. Oral Methylthioadenosine Administration Attenuates Fibrosis and Chronic Liver Disease Progression in Mdr2-/- Mice. Public Library of Science (PLoS), 2010.
Cita MLA (8a ed.)Latasa, M Ujue, et al. Oral Methylthioadenosine Administration Attenuates Fibrosis and Chronic Liver Disease Progression in Mdr2-/- Mice. Public Library of Science (PLoS), 2010.
Precaución: Estas citas no son 100% exactas.